Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
S

Novel Salvage Therapy in Mantle Cell Lymphoma: Discussion on Agents Other than BTKi and Venetoclax, Ibrutinib Combinations

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Simon Rule
By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Simon Rule
314 views
October 18, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Related Content

AUTOPLAY
08:18
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…

Feat. A. Zhou
09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin
16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein
06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
10:49
Monia Marchetti

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

10:24
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on Optimal Treatment of MCL: Future Strategies

Feat. M. Dreyling
15:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Update on Dissecting the Biology of MCL: What Is Clinicall…

Feat. T. Witzig
05:24
2021 ASCO Virtual Direct™ Highlights

2021 ASCO Key Takeaways on Lymphoma: Selected Trials on CLL & HL…

Feat. M. Kamdar
17:34
2021 ASCO Virtual Direct™ Highlights

ASCO 2021 Q&A Session on Key Clinical Data in Leukemia & Lym…

Feat. C. McMahon, M. Kamdar
25:01
Indy Hematology Review

Review of Emerging Therapies and Top Trials in Hematologic Malignanc…

Feat. R. Birhiray
32:02
2021 ASCO Virtual Direct™ Highlights

ASCO 2021 Q&A Session on New Updates in Hematologic Malignancies

Feat. D. Maloney, M. Percival
22:32
2021 ASCO Virtual Direct™ Highlights

2021 ASCO Q&A on Practice-Changing Abstracts in Lymphoma and Leu…

Feat. J. Soumerai, T. Kadia
19:41
2021 ASCO Virtual Direct™ Highlights

2021 ASCO Lymphoma and Leukemia Q&A Session: Impact of Recent Tr…

Feat. J. Svoboda, R. Redner
12:35
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

2019 Frontline Therapy for Mantle Cell Lymphoma: Cytarabine as a Key…

Feat. S. Rule
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
13:07
Moffitt Cancer Center

R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?

Feat. J. Chavez
09:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Random…

Feat. J. Westin
06:33
Christopher Flowers

FDA Approval of Zanubrutinib in R/R FL: What You Need to Know

10:04
Tara Graff

How to Incorporate Bispecific Antibodies Into Your NHL Practice: A P…

11:12
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826, a Randomized Study of Nivo-AV…

Feat. A. Herrera